Active Commuters Have Lower Risks for Morbidity, Mortality
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 17, 2024 -- Active commuters who cycle or walk to work have lower risks for morbidity and mortality, according to a study published online July 16 in BMJ Public Health.
Catherine Friel, from the University of Glasgow in the United Kingdom, and colleagues examined prospective associations with multiple health outcomes over 18 years for pedestrians and cyclists using data for 82,297 individuals aged 16 to 74 years from the Scottish Longitudinal Study. Cyclist and pedestrian commuters were compared to nonactive commuters for a range of health outcomes.
The researchers found that cyclist commuting was associated with lower risks for all-cause mortality, any hospitalization, cardiovascular disease (CVD) hospitalization, and having a CVD prescription compared with nonactive commuting (hazard ratios, 0.53, 0.90, 0.76, and 0.70, respectively) and with lower risks for cancer mortality, cancer hospitalization, and having a prescription for mental health problems (hazard ratios, 0.49, 0.76, and 0.80, respectively). Pedestrian commuting was associated with lower risks for any hospitalization, CVD hospitalization, having a CVD prescription, and having a mental health prescription (hazard ratios, 0.91, 0.90, 0.90 and 0.93, respectively).
"These findings provide direct evidence of the health benefits of active commuting in a Scottish context, supporting current policy," the authors write. "This study has wider global relevance to efforts to reduce carbon emissions and to shift to more active and sustainable travel modes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use
THURSDAY, April 24, 2025 -- School-based asthma therapy (SBAT) can help improve children’s asthma control and decrease acute health care utilization, according to a study...
Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis
THURSDAY, April 24, 2025 -- For patients with bronchiectasis, brensocatib leads to a lower annualized rate of pulmonary exacerbations, according to a study published in the April...
Cold Hypersensitivity, Heavy Leg Sensation Tied to Risk for Varicose Veins
THURSDAY, April 24, 2025 -- Cold hypersensitivity and a feeling of heaviness in the legs are linked to the presence of varicose veins in adults aged 30 years and older, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.